Skip to content
Native Collagen / Oral Tolerance Agent

Undenatured Type II Collagen (UC-II)

Native, undenatured type II collagen from chicken sternum, taken at 40 mg a day: a dose about 250 times smaller than collagen peptides, because the proposed mechanism is oral tolerance, not substrate. One multicentre trial in 191 people with knee osteoarthritis found it beat placebo and glucosamine-chondroitin over six months. Every human trial so far was run or funded by the ingredient's supplier, and no independent replication exists. Grade C: a reasonable 12-week trial, not a settled answer.

joint-health
Tier A— Well-tolerated — strong human evidence
Evidence gradeC — Animal studies / Case reports
BH

Editorially reviewed by

BiohackingHub Research Team

Editorial Team · Last updated: November 11, 2026

What It Is, and Why the Dose Is So Small

UC-II is type II collagen extracted from chicken sternum cartilage at low temperature so that the protein keeps its native, triple-helix shape. That shape is the point. Collagen peptides are type I collagen chopped into small fragments and taken at 5–10 g a day as a raw material. UC-II is taken at 40 mg a day, delivering roughly 10 mg of intact collagen, because the proposed mechanism is not supply but signalling: intact collagen epitopes reaching the immune tissue of the gut wall, the Peyer's patches, are thought to induce oral tolerance, damping the immune reaction against the body's own cartilage type II collagen. The mechanism was described by the people who developed the material, in a paper that included a five-person pilot.

What the Human Trials Show

  • The pivotal trial, 191 people with knee osteoarthritis, 180 days. Participants took UC-II 40 mg, glucosamine 1,500 mg plus chondroitin 1,200 mg, or placebo. At day 180, total WOMAC was better on UC-II than placebo (P=0.002) and than glucosamine-chondroitin (P=0.04), with pain, stiffness and function all separating from placebo. The abstract reports P values, not effect sizes. Two of the three authors worked for the supplier.
  • Healthy adults with exercise knee pain, 55 people, 120 days. UC-II improved knee extension (81.0° against 74.0°) and time to discomfort on a stepper (2.8 against 1.4 minutes) over placebo. Supplier-linked.
  • An earlier 90-day trial compared UC-II with glucosamine-chondroitin and reported a 33% fall in WOMAC against 14%. It had no placebo arm, and in osteoarthritis the placebo response alone is a moderate effect size of about 0.5.

Reviews from 2023 and 2025 call it safe and promising in the short to medium term and ask for larger trials. A 2018 meta-analysis of 20 supplements found UC-II among only two with a clinically important effect at medium term, and on very low quality evidence.

The Problem: One Sponsor

We found no placebo-controlled trial of UC-II run independently of its supplier. That does not make the results wrong, but it is the same pattern that, for glucosamine, turned a positive literature into a null one once public money funded the trials. Grade C, and it stays C until someone without a stake replicates the 191-person result.

Dose and How to Run It

40 mg once a day, on its own, for 12 weeks, scored against a pain and function baseline. If nothing has changed at 12 weeks, stop. Do not combine it with a different collagen in the same trial period; the comparison in Collagen for Joints: Hydrolysed Peptides vs Undenatured Type II explains why the two are different products with different evidence.

Safety

The trials reported tolerability similar to placebo. The material is chicken-derived, so people with chicken or egg allergy should avoid it. There are no documented drug interactions, and at 40 mg there is nothing pharmacologically large to interact with.

Where It Fits

UC-II is the optional Layer 2 in the Knee Osteoarthritis Supplement Trial, run only after a Layer 1 compound has had its 12 weeks. For the larger-dose, type I collagen used for skin and tendons, see collagen peptides.

Stacking Interactions

How Undenatured Type II Collagen (UC-II) interacts with other compounds

=
Collagen PeptidesNeutralweak evidence

Do not substitute one for the other. A 10 g scoop of collagen peptides is not a UC-II dose, and 40 mg of UC-II is not a collagen-peptide dose

=
GlucosamineNeutralweak evidence

UC-II scored better than the combination on total WOMAC (P=0.04) in that supplier-run trial. One trial, one sponsor

Protocols using Undenatured Type II Collagen (UC-II)

Evidence-graded stacks that include this compound

Safety Profile — Tier A

Well-tolerated — strong human evidence

Contraindications

  • ●Chicken or egg allergy — the material comes from chicken sternum cartilage
  • ●Pregnancy and breastfeeding — not studied

Side Effects

  • ●Tolerability similar to placebo in the 191-person trial; occasional mild stomach upset

Drug Interactions

No interactions documented